Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis

This meta-analytic study explored the relationship between the risk of type 2 diabetes mellitus (T2DM) and bisphenol A concentrations. The Embase and Medline (PubMed) databases were searched, using relevant keywords, for studies published between 1980 and 2018. A total of 16 studies, twelve cross-se...

Full description

Saved in:
Bibliographic Details
Published inBMC endocrine disorders Vol. 18; no. 1; pp. 81 - 10
Main Authors Hwang, Semi, Lim, Jung-eun, Choi, Yoonjeong, Jee, Sun Ha
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 06.11.2018
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN1472-6823
1472-6823
DOI10.1186/s12902-018-0310-y

Cover

Loading…
More Information
Summary:This meta-analytic study explored the relationship between the risk of type 2 diabetes mellitus (T2DM) and bisphenol A concentrations. The Embase and Medline (PubMed) databases were searched, using relevant keywords, for studies published between 1980 and 2018. A total of 16 studies, twelve cross-sectional, two case-control and one prospective, were included in the meta-analysis. The odds ratio (OR) and its 95% confidence interval (CI) were determined across the sixteen studies. The OR and its 95% CI of diabetes associated with bisphenol A were estimated using both fixed-effects and random-effects models. A total of 41,320 subjects were included. Fourteen of the sixteen studies included in the analysis provided measurements of urine bisphenol A levels and two study provided serum bisphenol A levels. Bisphenol A concentrations in human bio-specimens showed positive associations with T2DM risk (OR 1.28, 95% CI 1.14, 1.44). A sensitivity analysis indicated that urine bisphenol A concentrations were positively associated with T2DM risk (OR 1.20, 95% CI 1.09, 1.31). This meta-analysis indicated that Bisphenol A exposure is positively associated with T2DM risk in humans.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:1472-6823
1472-6823
DOI:10.1186/s12902-018-0310-y